Figure 1From: The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care Prevalence of pharmacologically treated attention deficit hyperactivity disorder (methylphenidate, dexamfetamine or atomoxetine) in patients aged 6-years and over in UK general practice (with 95% confidence intervals). Back to article page